Cubist Systematic Strategies’s LianBio American Depositary Shares LIAN Stock Holding History

Cubist Systematic Strategies’s Portfolio LIAN Stock Details LIAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-19,179	Closed	-$85.7K	–	4423
2023 Q4	$85.7K	Buy	+19,179	New	+$66K	﹤0.01%	3205
2022 Q3	–	Sell	-32,300	Closed	-$70K	–	4867
2022 Q2	$70K	Buy	+32,300	New	+$110K	﹤0.01%	4040
2022 Q1	–	Sell	-11,095	Closed	-$68K	–	3862
2021 Q4	$68K	Buy	+11,095	New	+$127K	﹤0.01%	3271

Other funds holding LIAN

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Cubist Systematic Strategies's LIAN Position: Q1 2024 in Review

Cubist Systematic Strategies sold out of LianBio American Depositary Shares (LIAN) in Q1 2024, closing a stake of 19,179 shares — an estimated $85.7K sold.

Cubist Systematic Strategies first reported a position in LIAN in Q4 2021 and held it in 3 quarters. The position peaked at $85.7K in Q4 2023. 3 funds tracked by Wall St. Rank hold LIAN as of Q1 2024.

Cubist Systematic Strategies reported no remaining LianBio American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Cubist Systematic Strategies sold 19,179 LianBio American Depositary Shares shares in Q1 2024, an estimated $85.7K.
Cubist Systematic Strategies first reported a position in LianBio American Depositary Shares in Q4 2021 and held it in 3 quarters.
Cubist Systematic Strategies's LianBio American Depositary Shares position peaked at $85.7K in Q4 2023.
3 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2024.

Based on Cubist Systematic Strategies's 13F filing for Q1 2024, filed 15 May 2024.